Frankfurt - Delayed Quote EUR

CVS Group plc (4C9.F)

Compare
11.50
-0.10
(-0.86%)
As of 8:13:02 AM GMT+2. Market Open.
Loading Chart for 4C9.F
  • Previous Close 11.60
  • Open 11.50
  • Bid 11.20 x 100000
  • Ask 11.40 x 100000
  • Day's Range 11.50 - 11.50
  • 52 Week Range 9.30 - 14.20
  • Volume 34
  • Avg. Volume 50
  • Market Cap (intraday) 844.815M
  • Beta (5Y Monthly) 1.06
  • PE Ratio (TTM) 35.94
  • EPS (TTM) 0.32
  • Earnings Date Feb 27, 2025
  • Forward Dividend & Yield 0.10 (0.83%)
  • Ex-Dividend Date Oct 31, 2024
  • 1y Target Est --

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through Veterinary Practices, Laboratories, Crematoria, and Online Retail Business segments. It operates in animal veterinary practices and complementary veterinary diagnostic businesses. In addition, the company provides pet cremation and clinical waste disposal services for veterinary practices. CVS Group plc operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products; and an online dispensary. Further, the company provides burial grounds; veterinary instrumentation supply; and property development services. CVS Group plc owns veterinary practices, laboratories, and crematories in the United Kingdom, Australia, the Netherlands, and the Republic of Ireland. The company was founded in 1999 and is headquartered in Diss, the United Kingdom.

www.cvsukltd.co.uk

9,000

Full Time Employees

June 30

Fiscal Year Ends

Recent News: 4C9.F

View More

Performance Overview: 4C9.F

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

4C9.F
16.75%
FTSE 100 (^FTSE)
0.43%

1-Year Return

4C9.F
6.30%
FTSE 100 (^FTSE)
2.03%

3-Year Return

4C9.F
42.20%
FTSE 100 (^FTSE)
7.66%

5-Year Return

4C9.F
30.03%
FTSE 100 (^FTSE)
50.27%

Compare To: 4C9.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4C9.F

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    852.16M

  • Enterprise Value

    1.19B

  • Trailing P/E

    36.05

  • Forward P/E

    10.48

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.04

  • Price/Book (mrq)

    2.66

  • Enterprise Value/Revenue

    1.49

  • Enterprise Value/EBITDA

    9.17

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.42%

  • Return on Assets (ttm)

    4.20%

  • Return on Equity (ttm)

    7.43%

  • Revenue (ttm)

    668.6M

  • Net Income Avi to Common (ttm)

    19.4M

  • Diluted EPS (ttm)

    0.32

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.6M

  • Total Debt/Equity (mrq)

    113.05%

  • Levered Free Cash Flow (ttm)

    28.3M

Research Analysis: 4C9.F

View More

Company Insights: 4C9.F

Research Reports: 4C9.F

View More